Advanced Health Intelligence - AHI Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.36
+0 (0.00%)

This chart shows the closing price for AHI by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Advanced Health Intelligence Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AHI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AHI

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Advanced Health Intelligence in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $0.36.

This chart shows the closing price for AHI for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in Advanced Health Intelligence. This rating has held steady since December 2022, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/1/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/30/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/30/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/28/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/26/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/25/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/23/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/25/2023

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/18/2022Maxim GroupInitiated CoverageBuy$11.00High
(Data available from 3/26/2018 forward)

News Sentiment Rating

1.47 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/27/2022
  • 3 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/26/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/26/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/25/2022
  • 2 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/25/2022
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/24/2023
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/23/2023
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/25/2023

Current Sentiment

  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.
Advanced Health Intelligence logo
Advanced Health Intelligence Ltd. operates as a mobile application and technology development company in Australia and internationally. It develops and patents BodyScan, a proprietary measurement/dimensioning technology that enables end-user to check and assess body dimensions using a smartphone. The company also provides FaceScan for measuring vital signs, and risks associated with cardiovascular disease, heart attack, and stroke; and DermaScan, a dermatological scanner. It serves mobile health and telehealth, life and health insurance, fitness and wellness, and consumer apparel sectors. The company was formerly known as Advanced Human Imaging Limited and changed its name to Advanced Health Intelligence Ltd. in December 2022. Advanced Health Intelligence Ltd. was incorporated in 2014 and is based in South Perth, Australia.
Read More

Today's Range

Now: $0.36
Low: $0.36
High: $0.38

50 Day Range

MA: $0.46
Low: $0.36
High: $0.59

52 Week Range

Now: $0.36
Low: $0.35
High: $2.08

Volume

4,068 shs

Average Volume

19,701 shs

Market Capitalization

$10.08 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.86

Frequently Asked Questions

What sell-side analysts currently cover shares of Advanced Health Intelligence?

The following Wall Street analysts have issued research reports on Advanced Health Intelligence in the last year:
View the latest analyst ratings for AHI.

What is the current price target for Advanced Health Intelligence?

0 Wall Street analysts have set twelve-month price targets for Advanced Health Intelligence in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Advanced Health Intelligence in the next year.
View the latest price targets for AHI.

What is the current consensus analyst rating for Advanced Health Intelligence?

Advanced Health Intelligence currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for AHI.

What other companies compete with Advanced Health Intelligence?

How do I contact Advanced Health Intelligence's investor relations team?

The company's listed phone number is 61-8-9324-2099 and its investor relations email address is [email protected] The official website for Advanced Health Intelligence is ir.advancedhumanimaging.com. Learn More about contacing Advanced Health Intelligence investor relations.